Home Trending Stocks Why Chromadex Corp. (CDXC) Remains A Gainer After Ring Of The Bell?

Why Chromadex Corp. (CDXC) Remains A Gainer After Ring Of The Bell?

The biotechnology company ChromaDex Corporation (CDXC) continued the rally after ring of the bell on Thursday rising +18.68%. During the regular session price of the stock skyrocketed 92.40% concluding at $18.74.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What is causing the surge?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


The ChromaDex Corporation is a global bioscience company with a passion for healthy aging. Research at ChromaDex leads the way in pioneering studies of nicotinamide, a nutrient that becomes depleted with age. ChromaDex is regarded as the inventor of nicotinamide riboside (NR), the active form of NAD+, and other NAD+ precursors, which is in ChromaDex’s patent portfolio.

Read More

ChromaDex Corp. reveals results from its study on “Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19” on Wednesday. A preprint of these studies appeared on the medRxiv website on Feb. 20. An added nutritional protocol to standard treatment reduced recovery time by 3.5 days in patients with mild-to-moderate COVID-19 when compared to standard care.

Researchers with the ChromaDex External Research Program (CERP) and ScandiBio Therapeutics have followed up findings from Phase 2 clinical data published in October 2020 with the findings from the current study. With the introduction of the nutritional protocol, or combined metabolic activators (CMA), into the Turkish standard of care, recovery time declined and liver health improved, as well as markers of inflammation declined.

Researchers examined 309 outpatient patients at Umraniye Teaching and Research Hospital, University of Health Sciences, Istanbul, Turkey, in a Phase 3 randomized, placebo-controlled and double-blind clinical trial. The Nutritional Protocol or Placebo was given on a three-to-one basis in combination with either hydroxychloroquine (HCQ) or favipiravir (FP). For five days patients were given standard care, and then the nutritional protocol or placebo for two weeks.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The publication of an achievement towards treatment of COVID-19 caused the stock price to almost double its value in a day on Thursday, and the surge remain even after ring of the bell on the day.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Is BTZI Stock Increasing Today?

The stock price of BOTS, Inc. (OTCPink: BTZI) has been rising more than 7% today and was buoying at $0.1266 at the last check....

Why Has The KBSF Stock Price Gained 10% In Last Session?

As of Friday's normal trading session, the price of KBS Fashion Group Limited (NASDAQ: KBSF) rose $0.26 or 9.96% to conclude at $2.87. KBS...

Why Royal Bank of Canada (RY) stock plummeted in after-hours on Friday?

Royal Bank of Canada (RY) stock lost 64.36% in the extended hour trading session on Friday, April 16, 2021. The RY stock gained merely...

Why Did The CMCL Stock Rise By 8% In Last Trading?

Caledonia Mining Corporation Plc (NYSE: CMCL) gained 8.91% during the trading session on Thursday. The share price reached a low of $13.70 and a...

Why Progyny Inc (PGNY) stock gained on Thursday, April 15?

Progyny Inc (PGNY) stock gained 7.31% in the after-hours session on Thursday, April 15, 2021, after it gained 0.94% in the early session.  PGNY...

Is This Why The APLD Stock Skyrocketed Last Trading?

Applied Science Products, Inc. (OTCPK: APLD) closed at $0.635 and experienced a 215.92% increase on Friday. A total of 2.07M shares of Applied Science...

The CRSS Stock Increased 82% In The Last Session Due To What?

Stock of Crossroads Systems, Inc. (OTCQX: CRSS) gained 81.82% or $18.00 in Friday's trading session, closing the day at $40.00 a share. Crossroads Systems...

How Did The ZVO Stock Appreciate 9% In The Last Trading Session?

Zovio Inc (NASDAQ: ZVO) normally sees about 413.34K shares traded on a regular business day but on a Friday it saw a bit higher...

Related News

Why Is BTZI Stock Increasing Today?

The stock price of BOTS, Inc. (OTCPink: BTZI) has been rising more than 7% today and was buoying at $0.1266 at the last check....

Why Has The KBSF Stock Price Gained 10% In Last Session?

As of Friday's normal trading session, the price of KBS Fashion Group Limited (NASDAQ: KBSF) rose $0.26 or 9.96% to conclude at $2.87. KBS...

Why Royal Bank of Canada (RY) stock plummeted in after-hours on Friday?

Royal Bank of Canada (RY) stock lost 64.36% in the extended hour trading session on Friday, April 16, 2021. The RY stock gained merely...

Why Did The CMCL Stock Rise By 8% In Last Trading?

Caledonia Mining Corporation Plc (NYSE: CMCL) gained 8.91% during the trading session on Thursday. The share price reached a low of $13.70 and a...

Why Progyny Inc (PGNY) stock gained on Thursday, April 15?

Progyny Inc (PGNY) stock gained 7.31% in the after-hours session on Thursday, April 15, 2021, after it gained 0.94% in the early session.  PGNY...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.